Success isn't just about action; it's about focus. Saying "no" to distractions and detours is the ultimate test of commitment ...

Trichuris incognita is a newfound intestinal roundworm closely related to the whipworm parasite. However, it is significantly ...

After three years of VP250, 83.5% of participants reached an eliciting dose (ED) of ≥1000 mg, an increase from 64.2% at month ...

Nurse-led care effectively reduces disease activity and improves self-efficacy in patients with rheumatoid arthritis, ...

Important milestone for Biotest: Biologics License Application for Fibrinogen submitted to the US Food and Drug Administration (FDA) Biotest's fibrinogen aims to fulfill a high unmet medical need for ...

Abenacianine, a tumor-targeted fluorescent imaging agent, received fast track designation from the FDA after demonstrating ...

With high biologic treatment failure rates common among patients who have hidradenitis suppurativa (HS), investigators set ...

A three-step skincare regimen improved acne and post-acne sequelae in adults with diverse skin types, according to a ...

DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study EPITOPE OLE data demonstrates continued improvement in treatment ...

BOSTON, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics ...

Obesity is a severe public health problem, contributing significantly to the global non-communicable disease burden, ...